transdermal drug delivery

ORLANDO, Fla., May 15, 2018  — Nutriband Inc. (OTC: NTRB), a Nevada Corporation, is pleased to announce that it has appointed Jeff Patrick PharmD as Chief Scientific Officer and to head of its Pharmaceutical Advisory Board. Dr. Jeff Patrick Jeff Patrick Pharm.D. currently serves as Director of Drug Development Institute at the Ohio State University Comprehensive Cancer Center. Dr. Patrick …

Nutriband Inc. Announces the Appointment of Dr. Jeff Patrick as Chief Scientific Officer and to Head of Advisory Board Read More »

ORLANDO, Fla., April 10, 2018 /PRNewswire/ — Nutriband Inc. (OTC: NTRB), a Nevada Corporation, is pleased to announce the acquisition of 4P Therapeutics Inc. on April 5, 2018.   Nutriband has acquired 100% interest in 4P Therapeutics for a total of $1,900,000 payable in both company stock and cash.  4P Therapeutics will receive 250,000 shares of common stock and a …

Nutriband Inc. Acquires 4P Therapeutics Inc. Read More »